Search
for
Sort by
Research 61–90 of 130
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Update on the dermatologic use of systemic glucocorticosteroids
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Hypersensitivity Reactions to Anticoagulant Drugs
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- The spectrum of nephrocutaneous diseases and associations
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Skin
- Finasteride in Androgenic Alopecia
- Dermatological Drugs, Topical Agents, and Cosmetics
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Poster Abstracts
- TOC
- Cutaneous manifestations of systemic infection in children
- Clinical manifestations of cutaneous lupus erythematosus
- A Permanent Hair Loss in a Patient with Hypersensitivity to Intralesional Triamcinolone Injection
- Cutaneous lupus erythematosus
- Psychotropic Treatment of Psychodermatologic Disorders
- Ingestion of topical steroid triggering pustular psoriasis?
- Cutaneous manifestations of COVID-19
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- ZALCITABINE
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations